SCHEMBL21923933

SCHEMBL21923933

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4ccc5c(c4)-c4ccccc4C54c5ccccc5C(c5ccccc5)(c5ccccc5)c5ccccc54)cc3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 2/20 0.42
OPRK1 P41145 1/20 0.42
PDK2 Q15119 9/20 0.38
L3MBTL1 Q9Y468 2/20 0.35
THRB P10828 2/20 0.35
APAF1 O14727 1/20 0.35
NPC1 O15118 1/20 0.35
XBP1 P17861 1/20 0.35
PTBP1 P26599 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
GALK1 P51570 1/20 0.35
BLM P54132 1/20 0.35
SMAD3 P84022 1/20 0.35
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21923882 1.00 MAPT (0.42) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL21559459 0.99 MAPT (0.41) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL21924582 0.99 MAPT (0.41) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL21559002 0.97 MAPT (0.42) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL16812262 0.97 MAPT (0.45) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL16812261 0.96 MAPT (0.44) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL18998382 0.96 MAPT (0.44) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL21923899 0.95 MAPT (0.39) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL21923950 0.95 MEN1 (0.39) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL21559476 0.94 KDM4E (0.42) MAPTMEN1KMT2ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3567026-B1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME LG CHEMICAL LTD (KR) 2021-12-29 EP disclosed
US-20200131112-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131112-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME AOX1, CYP1B1, CRY1 MAPT 2292/4885MEN1 558/4885KMT2A 1904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.